FI970823A - Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia - Google Patents

Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia Download PDF

Info

Publication number
FI970823A
FI970823A FI970823A FI970823A FI970823A FI 970823 A FI970823 A FI 970823A FI 970823 A FI970823 A FI 970823A FI 970823 A FI970823 A FI 970823A FI 970823 A FI970823 A FI 970823A
Authority
FI
Finland
Prior art keywords
delta
antagonist effects
concomitant
agonist
opioid receptor
Prior art date
Application number
FI970823A
Other languages
English (en)
Swedish (sv)
Other versions
FI970823A0 (fi
Inventor
Peter Schiller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI970823A publication Critical patent/FI970823A/fi
Publication of FI970823A0 publication Critical patent/FI970823A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI970823A 1994-08-30 1997-02-27 Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia FI970823A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402880A SE9402880D0 (sv) 1994-08-30 1994-08-30 New peptide derivatives
PCT/SE1995/000918 WO1996006855A1 (en) 1994-08-30 1995-08-10 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS

Publications (2)

Publication Number Publication Date
FI970823A true FI970823A (fi) 1997-02-27
FI970823A0 FI970823A0 (fi) 1997-02-27

Family

ID=20395061

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970823A FI970823A0 (fi) 1994-08-30 1997-02-27 Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia

Country Status (12)

Country Link
US (1) US5811400A (fi)
EP (1) EP0776332A1 (fi)
JP (1) JPH10504837A (fi)
CA (1) CA2197566A1 (fi)
FI (1) FI970823A0 (fi)
IL (1) IL114664A0 (fi)
NO (1) NO970889L (fi)
NZ (1) NZ292287A (fi)
SE (1) SE9402880D0 (fi)
TR (1) TR199501076A2 (fi)
WO (1) WO1996006855A1 (fi)
ZA (1) ZA956561B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
SE9604789D0 (sv) * 1996-12-20 1996-12-20 Astra Ab New Compounds
DE60010891T2 (de) * 1999-08-13 2005-06-09 Southern Research Institute, Birmingham Pyridomorphinanen und ihre verwendung
WO2001036006A1 (en) * 1999-11-19 2001-05-25 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US6916905B2 (en) * 2000-03-24 2005-07-12 The United States Of America As Represented By The Department Of Health And Human Services Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use
US6753317B1 (en) 2000-03-24 2004-06-22 The United States Of America As Represented By The Department Of Health And Human Services Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use
PT1392291E (pt) 2000-10-30 2007-08-24 Janssen Pharmaceutica Nv Inibidores da tripeptidil-peptidase
US7041681B2 (en) 2002-04-29 2006-05-09 Janssen Pharmaceutica N.V. Compounds as opioid receptor modulators
PL1725537T3 (pl) 2004-03-15 2011-12-30 Janssen Pharmaceutica Nv Nowe związki jako modulatory receptorów opioidowych
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US20060104907A1 (en) * 2004-11-16 2006-05-18 Government Of The U.S.A., Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use
US8030341B2 (en) * 2005-09-01 2011-10-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Dmt-derivative compounds and related compositions and methods of use
WO2008016913A1 (en) * 2006-07-31 2008-02-07 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Biologically potent analogues of the dmt-tic pharmacophore and methods of use
TWI468375B (zh) 2008-10-27 2015-01-11 Janssen Pharmaceutica Nv 製備經保護之l-丙胺酸衍生物之方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides
CA2090171A1 (en) * 1993-02-23 1994-08-24 Peter W. Schiller Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds

Also Published As

Publication number Publication date
CA2197566A1 (en) 1996-03-07
SE9402880D0 (sv) 1994-08-30
ZA956561B (en) 1996-02-29
AU3401695A (en) 1996-03-22
NO970889D0 (no) 1997-02-27
NZ292287A (en) 1998-02-26
IL114664A0 (en) 1995-11-27
FI970823A0 (fi) 1997-02-27
TR199501076A2 (tr) 1996-06-21
NO970889L (no) 1997-02-27
JPH10504837A (ja) 1998-05-12
EP0776332A1 (en) 1997-06-04
WO1996006855A1 (en) 1996-03-07
AU695175B2 (en) 1998-08-06
US5811400A (en) 1998-09-22

Similar Documents

Publication Publication Date Title
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
DE69734833D1 (de) Vitronektin rezeptor antagonisten
TR199600001A2 (tr) Estrojen agonistleri / antagonistleri.
EE9800171A (et) 3-pürasoolkarboksamiidi derivaadid, mis omavad afiinsust kannabinoidretseptori suhtes
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
NO20012411D0 (no) Pyrrolidin-derivater-CCR-3-reseptorantagonister
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
IS5294A (is) 4-Amínópýrról (3,2-d) pýrimidín sem mótlyf fyrir taugapeptíð Y viðtaka
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
FI970823A (fi) Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia
TR199600359A2 (tr) Adezyon reseptörü antagonistleri.
FI961628A (fi) Indolijohdannaisia NMDA-antagonisteina
ID24726A (id) Antagonis-antagonis reseptor trombin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0882066T3 (da) Peptidderivater
FI960223A0 (fi) 1,5-bentsodiatsepiinijohdannaisia, jotka ovat käyttökelpoisia CCK- tai gastriiniantagonisteina
BR9609671A (pt) Amino uracilas substituídas
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69513832D1 (de) Exzitatorische aminosäure-rezeptor-antagonisten
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
FI973671A0 (fi) Heterosyklisen substituentin sisältäviä piperatsinonijohdoksia takykiniinireseptoriantagonisteina
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina